A 22-week, Multicenter, Randomized, Double-blind Controlled Trial Of Crocus Sativus In The Treatment Of Mild-to-moderate Alzheimer's Disease
Notes for this study:
|Number of Subjects
Supplementation of 15mg saffron extract twice daily over the course of 18 weeks (with a 4 week run in period with 15mg once daily) in persons with Alzheimer's disease failed to see significant benefits relative to either the reference drug (donepezil at 10mg) or to baseline on ADAS-cog or CDR-SB. No placebo control was used in this study.